CJ Przybyl

Business news, market intelligence, and global industry analysis.

The Latest

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Representative image of an Accenture office building. The company is expanding its footprint in AI-driven insurance platforms and European defense engineering, as highlighted in its recent investments in Reserv and SIPAL.

Accenture (NYSE: ACN) doubles down on AI insurance and defense with Reserv investment, SIPAL buyout

Accenture (NYSE: ACN) fuels insurance AI with Reserv investment and strengthens defense engineering via SIPAL buyout, aligning with global reinvention strategy.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

June 5, 2025